Showing results (61-70 of 68) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Die Pharmazie|November 1, 2008
OIC-A006 promotes osteogenesis in vitro and in vivoMing Cai, Xiaodong Liu, Jin Shao, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 26, 2025
Dihydrotanshinone I targets the spike N-terminal domain to inhibit SARS-CoV-2 entry and spike-induced inflammationChan Yang, Kunyu Lu, Jinshen Wang, et al.Cell Death & Disease|May 2, 2023
KLF5 and p53 comprise an incoherent feed-forward loop directing cell-fate decisions following stressYizeng Yang, Dharmendra Bhargava, Xiao Chen, et al.Journal of Medicinal Chemistry|December 15, 2022
Identification of N- and C-3-Modified Laudanosoline Derivatives as Novel Influenza PAN Endonuclease InhibitorsYixian Liao, Yilu Ye, Mingjian Liu, et al.The American Surgeon|December 27, 2011
Endoscopic versus surgical treatment of downstream pancreatic duct stones in chronic pancreatitisJianguo Hong, Jian Wang, Alex M Keleman, et al.Cell Death and Differentiation|February 24, 2022
Cullin 4b-RING ubiquitin ligase targets IRGM1 to regulate Wnt signaling and intestinal homeostasisYujia Fan, Xiaohan Huo, Beibei Guo, et al.Journal of Translational Medicine|June 6, 2019
Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencingHui Cai, Changqing Jing, Xusheng Chang, et al.The Lancet. Oncology|July 11, 2025
Total neoadjuvant treatment with short-course radiotherapy followed by sintilimab plus capecitabine-oxaliplatin versus short-course radiotherapy followed by capecitabine-oxaliplatin in patients with locally advanced rectal cancer (SPRING-01): a single-centre, open-label, phase 2, randomised controlled trialFeng Tian, Honghai Dai, Dan Sha, et al.Pageof 7